Explore the socio-economic factors influencing vaccine hesitancy and its implications for public health policy.
Explore the socio-economic factors influencing vaccine hesitancy and its implications for public health policy.
Explore the socio-economic factors influencing vaccine hesitancy and its implications for public health policy.
Explore the socio-economic factors influencing vaccine hesitancy and its implications for public health policy.
Vaccine hesitancy—defined as the delay in acceptance or refusal of vaccination despite availability—presents a critical barrier to public health, particularly for efforts to contain infectious disease outbreaks like COVID-19. Socio-economic factors play a foundational role in shaping vaccine attitudes and intentions, often amplifying or mitigating other determinants such as personal risk perception, trust in institutions, and exposure to misinformation. A thorough understanding of these socio-economic drivers is crucial for designing and implementing effective public health policies.
Lower educational attainment and poor health literacy are consistently associated with increased vaccine hesitancy. Individuals with limited education often face challenges accessing, understanding, and appraising medical information, making them more vulnerable to vaccine misinformation and conspiracy theories[1][2][3]. This effect is noted across diverse settings, from high-income countries to marginalized urban populations, underlining the universality of its impact[1][3].
Lower socio-economic status—often operationalized as limited income or unemployment—increases practical and psychological barriers to vaccination. Economic insecurity can make logistical issues like missing work for vaccine appointments or coping with side effects a significant deterrent. Furthermore, loss of income during the pandemic has been shown to correlate with greater hesitancy, with many individuals perceiving indirect vaccination costs (e.g., time off work, transportation) as prohibitive[4][5][6].
Marginalized social groups, including ethnic minorities, often display greater vaccine hesitancy, driven largely by historical and contemporary experiences of discrimination, medical exploitation, and systemic marginalization[5][7][8]. These experiences erode trust in healthcare systems and government institutions, making such groups more susceptible to both vaccine hesitancy and inequitable health outcomes[5][8]. For example, Black/African American populations in the US were found to have substantially higher odds of vaccine hesitancy, a disparity closely linked to both trust and exposure to racial inequities in healthcare[5].
Socio-economic positioning affects both the type and credibility of information individuals access. Lower-income or less-educated individuals may disproportionately rely on social media for health information, increasing vulnerability to misinformation[9][10][7]. High-profile analyses demonstrate that both negative discourse and coordinated online disinformation—often targeted at vulnerable populations—are strongly associated with decreased vaccination uptake at the population level[9][10][11]. Trust in traditional, authoritative information sources (e.g., healthcare providers, government communications) is a critical mediator: higher trust lowers hesitancy, while digital echo chambers reinforce it[12][7][13].
Rural, peri-urban, and resource-limited urban communities commonly experience reduced access to vaccination services due to fewer healthcare facilities, limited transportation, and logistical challenges[2][3][14]. These barriers often overlap with socio-economic disadvantage and may compound vaccine hesitancy by amplifying inconvenience and reinforcing perceptions of inadequacy in health system response[2][14].
Cultural and religious beliefs—often intersecting with SES and social marginalization—can shape both hesitancy and the spread of misinformation, as observed in sub-Saharan Africa[15], parts of Asia, and various minority populations globally[6][7][8]. Additionally, political orientation—such as right-wing affiliation in North American populations—has been found to correlate with greater vaccine skepticism and reduced uptake[16].
Public health messaging must account for the diversity of socio-economic contexts, customizing both content and channels of communication[17][6][13]. This includes use of local languages, engaging trusted community leaders, faith-based organizations, and influencers from within marginalized populations[15][7]. Tailored interventions should be designed to counter population-specific misinformation, correct myths, and resonate with community values[1][10][11].
Equitable access demands policy support for overcoming practical barriers—such as providing vaccination at workplaces, through mobile clinics, or in non-traditional settings (e.g., schools, community centers)[4][2][14]. Economic support policies, including paid leave for vaccination or managing side effects, and financial assistance for travel, can be especially effective for low-income populations and precarious workers[4][14].
Restoring confidence in vaccination requires acknowledging and addressing the roots of mistrust—both historical (e.g., medical abuse, discrimination) and contemporary (e.g., unequal treatment, lack of transparency in vaccine rollout)[5][7][8][18]. Engaging members of marginalized communities in planning and implementation processes, training health workers in culturally competent engagement, and public release of transparent safety and efficacy data strengthen trust[19][13][18].
Public health policies must directly address the challenge of online and offline misinformation[9][10][7]. Strategies include close collaboration with digital platforms to flag and correct false content, promotion of media literacy programs, and real-time debunking of circulating myths, especially in environments where access to credible information is unequal[9][10][11].
Real-time surveillance of vaccine attitudes across different socio-economic strata allows for data-driven allocation of resources and rapid deployment of targeted outreach to emerging hotspots of hesitancy[1][17][14]. Evaluation and adaptation of interventions based on community feedback and changing epidemiological circumstances are essential for sustained impact[20][13].
Interventions to reduce vaccine hesitancy should be integrated into broader social determinants of health efforts—addressing poverty, educational inequality, and healthcare access—thereby tackling root causes, rather than only symptoms, of vaccine reluctance[21][22]. For instance, increased vaccination coverage can be achieved by simultaneously improving health infrastructure and social services in underserved regions[14][22].
Failure to address the socio-economic drivers of vaccine hesitancy carries profound consequences. Even small declines in vaccine coverage—driven largely by nonmedical exemptions or hesitancy—can generate significant increases in disease incidence and healthcare costs[23]. For example, a 5% decline in measles coverage in US children could result in a threefold increase in cases and millions in added public sector expenses, underscoring the economic imperative for policies that raise and maintain high vaccination rates[23].
Socio-economic factors—including education, income, social marginalization, access to credible information, and geographic barriers—critically shape vaccine hesitancy. Trust—both in vaccines and institutions—emerges as a cross-cutting determinant, deeply conditioned by socio-economic context and past experiences[5][13][8][18]. Effective public health policy must therefore move beyond one-size-fits-all models: interventions must be context-sensitive, equity-driven, and integrated into broader efforts to rectify health and social inequities. By addressing these socio-economic determinants head-on, policymakers can not only enhance vaccine uptake in the present but also build resilient health systems better equipped for future public health crises.
AW, Junjie, et al. COVID-19 vaccine hesitancy—a scoping review of literature in high-income countries. Vaccines, 2021. https://doi.org/10.3390/vaccines9080900.
OKUBO, Ryo, et al. COVID-19 vaccine hesitancy and its associated factors in Japan. Vaccines, 2021. https://doi.org/10.3390/vaccines9060662.
DASGUPTA, Pallabi, et al. Vaccine hesitancy for childhood vaccinations in slum areas of siliguri, india. Indian Journal of Public Health, 2018. https://doi.org/10.4103/ijph.ijph_397_17.
SOARES, P., et al. Factors associated with COVID-19 vaccine hesitancy. Vaccines, 2021. https://doi.org/10.3390/vaccines9030300.
WILLIS, Don E., et al. COVID‐19 vaccine hesitancy: Race/ethnicity, trust, and fear. Clinical and Translational Science, 2021. https://doi.org/10.1111/cts.13077.
JAFAR, Adib, et al. COVID-19 vaccine hesitancy in malaysia: Exploring factors and identifying highly vulnerable groups. PLoS ONE, 2022. https://doi.org/10.1371/journal.pone.0270868.
NAQVI, M., et al. Understanding COVID-19 vaccine hesitancy in ethnic minorities groups in the UK. Frontiers in Public Health, 2022. https://doi.org/10.3389/fpubh.2022.917242.
COURTNEY, Daniel S.; BLIUC, Ana‐Maria. Antecedents of vaccine hesitancy in WEIRD and east Asian contexts. Frontiers in Psychology, 2021. https://doi.org/10.3389/fpsyg.2021.747721.
WILSON, S.; WIYSONGE, C. Social media and vaccine hesitancy. BMJ Global Health, 2020. https://doi.org/10.1136/bmjgh-2020-004206.
GARETT, Renee; YOUNG, S. Online misinformation and vaccine hesitancy. Translational Behavioral Medicine, 2021. https://doi.org/10.1093/tbm/ibab128.
ROMATE, J., et al. What contributes to COVID-19 vaccine hesitancy? A systematic review of the psychological factors associated with COVID-19 vaccine hesitancy. Vaccines, 2022. https://doi.org/10.3390/vaccines10111777.
LIU, Piper Liping; ZHAO, Xinshu; WAN, Bo. COVID-19 information exposure and vaccine hesitancy: The influence of trust in government and vaccine confidence. Psychology, Health & Medicine, 2021. https://doi.org/10.1080/13548506.2021.2014910.
VUOLANTO, P., et al. Trust matters: The addressing vaccine hesitancy in europe study. Scandinavian Journal of Public Health, 2024. https://doi.org/10.1177/14034948231223791.
DECOUTTERE, C., et al. Insights into vaccine hesitancy from systems thinking, rwanda. Bulletin of the World Health Organization, 2021. https://doi.org/10.2471/blt.20.285258.
KABAKAMA, Severin, et al. Commentary on COVID-19 vaccine hesitancy in sub-saharan africa. Tropical Medicine and Infectious Disease, 2022. https://doi.org/10.3390/tropicalmed7070130.
GERRETSEN, P., et al. Individual determinants of COVID-19 vaccine hesitancy. PLoS ONE, 2021. https://doi.org/10.1371/journal.pone.0258462.
BAGIĆ, Dragan; ŠULJOK, Adrijana; ANČIĆ, Branko. Determinants and reasons for coronavirus disease 2019 vaccine hesitancy in croatia. Croatian Medical Journal, 2022. https://doi.org/10.3325/cmj.2022.63.89.
LALUMERA, E. Trust in health care and vaccine hesitancy. Rivista di estetica, 2018. https://doi.org/10.4000/estetica.3553.
JAIN, Jyoti, et al. COVID-19 vaccine hesitancy among medical students in india. Epidemiology and Infection, 2021. https://doi.org/10.1017/s0950268821001205.
PILTCH-LOEB, Rachael, et al. Determinants of the COVID-19 vaccine hesitancy spectrum. PLOS ONE, 2021. https://doi.org/10.1371/journal.pone.0267734.
TUCKERMAN, J.; KAUFMAN, J.; DANCHIN, M. Effective approaches to combat vaccine hesitancy. The Pediatric Infectious Disease Journal, 2022. https://doi.org/10.1097/inf.0000000000003499.
COOPER, S.; WIYSONGE, C. Towards a more critical public health understanding of vaccine hesitancy: Key insights from a decade of research. Vaccines, 2023. https://doi.org/10.3390/vaccines11071155.
LO, N.; HOTEZ, P. Public health and economic consequences of vaccine hesitancy for measles in the United States. JAMA Pediatrics, 2017. https://doi.org/10.1001/jamapediatrics.2017.1695.
tlooto can make mistakes. Check important information against the original sources.